Skip to main content
Midas Edge

Flyte Aviation, Inc.

For the period ended Mar 31, 2025. Filed May 14, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 14, 2025

VTAK$0.15-0.7%Stored close · as of Oct 2, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

ITEM 6. EXHIBITS

Exhibit · Incorporated by Reference
NumberDescriptionFormFile No.ExhibitFiling Date
3.1.1Amended and Restated Certificate of Incorporation of the Registrant.8-K001-386773.110/1/2018
3.1.2Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant. (effective 11/16/20)8-K001-386773.111/17/2020
3.1.3Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant. (effective 09/30/22)8-K001-386773.19/20/2022
3.1.3ACertificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant. (filed 08/01/23, effective 08/17/23)8-K001-386773.18/4/2023
3.1.3BCertificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant (filed 07/11/2024, effective 07/15/2024)8-K001-386773.17/12/2024
3.1.3CCertificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant (effective 1/13/2025)10-K001-386773.13/31/2025
3.1.4Certificate of Designation of Series X Convertible Preferred Stock.8-K001-386773.11/13/2023
3.1.5Certificate of Designation of Series A Preferred Stock.8-K001-386773.21/13/2023
3.1.5Certificate of Designation of Series B Preferred Stock.8-K001-386773.15/13/2025
3.2.1Amended and Restated Bylaws of the Registrant.8-K001-386773.210/1/2018
3.2.2Amendment to Amended and Restated Bylaws of the Registrant.8-K001-386773.18/17/2022
4.1Specimen common stock certificate of the Registrant.S-1333-2261914.17/16/2018
4.3Form of warrant issued in May 2020.8-K001-386774.15/22/2020
4.4Form of pre-funded warrant issued in May 2020.8-K001-386774.25/22/2020
4.5Form of placement agent warrant issued in May 2020.8-K001-386774.35/22/2020
4.6Form of warrant offered in July 2020.S-1333-2398874.37/16/2020
4.7Form of pre-funded warrant issued in July 2020.S-1333-2398874.47/16/2020
4.8Form of placement agent warrant offered in July 2020.S-1333-2398874.57/16/2020
4.9Form of placement agent warrant offered in October 20248-K001-386774.211/5/2024
4.10Form of Series B Warrant offered in February 2022.S-1/A333-2621954.92/3/2022
4.11Form of Series C Warrant issued in July 20228-K001-386774.17/22/2022
4.12Warrant Agency Agreement, dated February 8, 2022, by and between the Registrant and American Stock & Trust Company LLC.8-K001-386774.42/9/2022
4.12.1Amendment No. 1, dated July 22, 2022, to February 8, 2022 Warrant Agency Agreement by and between the Company and American Stock Transfer & Trust Company, LLC.10-Q001-386774.78/15/2022
4.13Form of Series E Warrant offered in January 2023.8-K001-386774.11/13/2023
4.14Form of Series F Warrant issued in March 2023.8-K001-386774.21/13/2023
4.15Form of Series G Warrant issued in March 2023.8-K001-386774.31/13/2023
4.16Form of Series H Common Stock Warrant issued September 20248-K001-386774.19/6/2024
4.17Form of Series I Common Stock Warrant issued September 20248-K001-386774.29/6/2024
4.18Form of Series J Common Stock Warrant issued September 20248-K001-386774.39/6/2024
4.19Form of Pre-Funded Common Stock Purchase Warrant issued September 20248-K001-386774.49/6/2024
4.20Form of Series K Warrant issued October 20248-K001-386774.110/25/2024
4.21Form of Placement Agent Warrant8-K/A001-386774.211/4/2024
4.22Form of Underwriters' Warrant offered in September 2024S-1333-2799304.176/26/2024
4.23Form of Warrant Agency Agreement dated as of September 3, 2024 entered into by and between the Registrant and Equiniti Trust Company, LLC8-K001-386774.59/6/2024
4.24Form of Series L Warrant offered in May 2025.8-K001-386774.15/13/2025
10.31.8Non-plan Stock Option Award granted January 6, 2025 to Philip Anderson10-K001-3867710.31.83/31/2025
10.31.9Offer Letter to Philip Anderson dated January 3, 202510-K001-3867710.31.93/31/2025
31.1*Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*@Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*@Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*Inline XBRL Instance Document
101.SCH*Inline XBRL Taxonomy Extension Schema Document
101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*Cover Page Interactive Data File (embedded within the Inline XBRL document).
*Filed herewith.
@The information in this exhibit is furnished and deemed not filed with the Securities and Exchange Commission for purposes of section 18 of the Exchange Act of 1934, as amended (Exchange Act), and is not to be incorporated by reference into any filing of Catheter Precision, Inc. under the Securities Act of 1933, as amended (Securities Act), or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.